TRxADE HEALTH, Inc. (NASDAQ:MEDS – Get Free Report) saw a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 15,000 shares, a decline of 35.1% from the August 15th total of 23,100 shares. Currently, 1.9% of the shares of the stock are sold short. Based on an average trading volume of 151,500 shares, the days-to-cover ratio is presently 0.1 days.
TRxADE HEALTH Stock Performance
Shares of NASDAQ MEDS traded up $0.04 during trading on Monday, reaching $7.37. The company had a trading volume of 12,555 shares, compared to its average volume of 212,095. TRxADE HEALTH has a twelve month low of $3.69 and a twelve month high of $44.56. The stock has a 50-day moving average price of $10.24 and a two-hundred day moving average price of $10.37.
TRxADE HEALTH (NASDAQ:MEDS – Get Free Report) last announced its quarterly earnings data on Friday, August 9th. The company reported ($1.04) EPS for the quarter. The business had revenue of $0.02 million during the quarter. TRxADE HEALTH had a negative net margin of 149.81% and a negative return on equity of 196.79%.
TRxADE HEALTH Cuts Dividend
Institutional Investors Weigh In On TRxADE HEALTH
An institutional investor recently bought a new position in TRxADE HEALTH stock. Virtu Financial LLC purchased a new stake in shares of TRxADE HEALTH, Inc. (NASDAQ:MEDS – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,617 shares of the company’s stock, valued at approximately $109,000. Virtu Financial LLC owned 0.75% of TRxADE HEALTH at the end of the most recent quarter. 5.68% of the stock is owned by hedge funds and other institutional investors.
TRxADE HEALTH Company Profile
TRxADE HEALTH, Inc operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace.
Further Reading
- Five stocks we like better than TRxADE HEALTH
- What is the FTSE 100 index?
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- How to Capture the Benefits of Dividend Increases
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- The 3 Best Retail Stocks to Shop for in August
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for TRxADE HEALTH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TRxADE HEALTH and related companies with MarketBeat.com's FREE daily email newsletter.